Skip to main content
. 2021 Apr 19;11:8501. doi: 10.1038/s41598-021-88080-3

Table 3.

Univariate survival analysis of OS and DFS after allo-HSCT x¯±s (N = 55).

Variables No. of patients OS DFS P
Rate/% P value Rate/% P value
Age 0.719 0.549
 ≤ 25 27 14.007 ± 2.052 12.263 ± 2.044
 > 25 28 18.621 ± 2.625 16.713 ± 2.596
Sex 0.906 0.591
Male 34 17.679 ± 2.380 16.791 ± 2.388
Female 21 15.2 ± 2.418 12.248 ± 2.297
Primary disease 0.187 0.296
ALL 23 20.761 ± 2.804 18.291 ± 2.888
AML 32 12.988 ± 1.886 11.918 ± 1.829
Gene mutation and/or fusion gene 0.872 0.891
Yes 41 18.087 ± 2.164 15.929 ± 2.16
No 14 14.571 ± 2.985 13.98 ± 2.886
Abnormal chromosome 0.984 0.45
Yes 21 14.681 ± 2.369 11.695 ± 2.286
No 34 17.774 ± 2.366 16.922 ± 2.363
Disease status at HSCT 0.433 0.392
CR1 41 18.756 ± 2.151 17.366 ± 2.163
CR2 and CR3 6 8.767 ± 3.407 8.767 ± 3.407
NR 8 13.813 ± 3.613 10.044 ± 3.128
MRD 0.030 0.005
Positive 18 10.194 ± 2.318 8.069 ± 1.971
Negative 37 20.422 ± 2.215 18.957 ± 2.246
Sex of donor–recipient 0.585 0.649
Identical 42 17.467 ± 2.172 16.697 ± 2.177
Different 13 13.777 ± 2.284 9.885 ± 2.145
Donor–recipient ABO compatibility 0.277 0.209
Compatible 25 12.976 ± 2.148 11.272 ± 2.077
Incompatible 30 19.607 ± 2.492 17.694 ± 2.517
Conditioning regimen 0.406 0.872
TBI/Cy-based 36 14.072 ± 1.846 13.386 ± 1.849
Bu/Cy-based 19 19.942 ± 3.119 15.622 ± 3.074
Donor source 0.298 0.545
Haploid donors 25 13.048 ± 2.137 12.192 ± 2.11
Unrelated donors 30 19.547 ± 2.504 16.765 ± 2.515
HLA matching 0.541 0.707
HLA-match donors 23 16.048 ± 2.303 14.388 ± 2.286
HLA-mismatched donors 32 16.863 ± 2.443 15.1 ± 2.41
GVHD prophylaxis 0.514 0.691
Control 14 12.914 ± 2.813 12.3 ± 2.705
Ruxolitinib 41 18.641 ± 2.17 16.554 ± 2.178
aGVHD 0.003 0.008
Yes 16 8.675 ± 2.377 8.258 ± 2.225
No 39 21.008 ± 2.133 18.785 ± 2.207
Grade II–IV aGVHD 0.002 0.003
Yes 11 7.173 ± 2.575 6.718 ± 2.312
No 44 20.277 ± 2.040 18.307 ± 2.088
cGVHD 0.003  < 0.001
Yes 16 26.9 ± 2.396 26.806 ± 2.448
No 39 11.967 ± 1.748 9.877 ± 1.608
Hemorrhagic cystitis 0.356 0.992
Yes 28 15.886 ± 2.569 15.789 ± 2.585
No 27 16.537 ± 2.134 13.521 ± 2.111
Pulmonary infection 0.105 0.445
Yes 37 15.7 ± 2.278 14.795 ± 2.262
No 18 18.533 ± 2.401 14.839 ± 2.573
Intestinal infection 0.703 0.41
Yes 16 13.125 ± 2.436 10.2 ± 2.046
No 39 18.503 ± 2.252 17.056 ± 2.258
EBV infection 0.282 0.205
Yes 4 13.25 ± 1.516 13.25 ± 1.516
No 51 17.286 ± 1.958 15.09 ± 1.926
CMV infection 0.279 0.193
Yes 43 15.986 ± 2.114 14.621 ± 2.09
No 12 19.1 ± 2.468 16.369 ± 2.598